Pharmaceutical Company Receives FDA Approval To Develop Brain Cancer Treatment Ropidoxuridine

Shuttle Pharmaceuticals Breaks New Ground with FDA Approval on Phase II Clinical Trial for Glioblastoma Treatment.

This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In an exciting development in the world of cancer treatment, Shuttle Pharmaceuticals has received the green light from the US Food and Drug Administration (FDA) to proceed with its Phase II clinical trial of Ropidoxuridin…